Facebook
Twitter
LinkedIn
ForwardISCC-PEG Pharmacogenomics Learning Series: Pharmacogenomics Resources
This online, self-paced, text-based module explores common nomenclature in pharmacogenomics (PGx). It was developed by the National Human Genome Research Institute (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG) and can be taken independently either free of charge or for continuing education credit depending upon the learner needs.
Target Audience
All healthcare professionals
Learning Objectives
Upon completion of this activity, participants should be able to:
- Review available evidence sources for pharmacogenomic recommendations.
- Describe the components of a CPIC guideline and how CPIC guidelines can be used by clinicians to make specific prescribing decisions for patient care.
- Explain how evidence-based guidelines are developed by CPIC.
- Retrieve the levels of evidence for gene/drug pairs.
- Integrate information from FDA, CPIC, and PharmGKB into pharmacogenomic clinical decision making.
Disclaimer Statement:
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Faculty:
Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series:
- Philip Empey, PharmD, PhD, FCCP (University of Pittsburgh School of Pharmacy)
- Andrew Monte, MD, PhD (University of Colorado)
- Trina Walker, DNP, APRN, FNP-C (Creighton University)
- Nguyen Park, MS, PA-C (National Human Genome Research Institute)
- Jeneva Gularte-Rinaldo, PhD, RN (Samuel Merritt University)
Course Directors:
- Philip Empey, PharmD, PhD - Associate Professor and Director, Pharmacogenomics Center of Excellence, University of Pittsburgh School of Pharmacy Executive Director, American Society of Pharmacovigilance for the Inter-Society Coordinating Committee for Practitioner Education in Genomics
- Ben Brown - Executive Director, American Society of Pharmacovigilance for the Inter-Society Coordinating Committee for Practitioner
Reviewers:
- Kelly Caudle, PharmD, PhD -Director, Clinical Pharmacogenetics Implementation Consortium
- Wendy Rubinstein, MD, PhD - Director, Personalized Medicine, Food & Drug Administration (Questions 1 and 3 only). The review does not constitute an endorsement by FDA or any of its employees.
Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 1.00 AAPA Category I CME
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance
The content for this training is not hosted on this website, please access the training via the Test2learn website:
https://programs.test2learn.org/course/view.php?id=49
You should log in or register here only after you review the educational content for this course.
To complete the course evaluation and receive your credits and certificate:
- Choose Register/Complete Course to complete the module.
- First time Users: If you have never completed training on this website, please select register in the upper right hand corner of the webpage.
- Returning Users: If you have completed training on this website, please log in in the upper right hand corner of the webpage.